Jing Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jing Li has a total of 131 co-authors. Here are the top co-authors by number of shared publications:
Yuchao Hou
Yueyang Hospital of Integrated Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China
6 shared publicationsJing Xie
Yueyang Hospital of Integrated Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China
5 shared publications- Huangan Wu
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
4 shared publications Lu Zhu
4 shared publicationsMengdie Wu
Yueyang Hospital of Integrated Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437
4 shared publicationsYan Huang
Shanghai Research Institute of Acupuncture and Meridian, Shanghai University of Traditional Chinese Medicine, Shanghai 200030, China
4 shared publications
Latest Publications
- Open Access
- 30 June 2026
- Published by Elsevier in Biomedical Journal
- p. 101013
Exploring the mechanism of acupuncture for Chronic Atrophic Gastritis based on bioinformatics and network topology strategies
- 30 June 2026
- Published by Elsevier in Biomedical Journal
- p. 101013
Open AccessExploring the mechanism of acupuncture for Chronic Atrophic Gastritis based on bioinformatics and network topology strategies
- Open Access
- 1 June 2026
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 19, 1-18
Acupuncture for Postherpetic Neuralgia: An Evidence Mapping
Objective: This study is to systematically evaluate the efficacy of acupuncture for PHN and provide a visual overview of treatment landscape. Methods: A systematic search was conducted in PubMed, Embase, Web of Science, China National Knowledge Infrastructure (CNKI), Chinese Scientific Journals Database (VIP), and Wanfang Database for systematic reviews (SRs) on acupuncture for PHN up to Apr 18, 2025. Studies were included if they were SRs of randomized controlled trials (RCTs) assessing traditional Chinese acupuncture interventions for PHN, and excluded if they involved non-traditional acupuncture, herpes zoster, or PHN prevention research. Two independent reviewers utilized Excel, EndNote 20, and R software for data analysis and assessed the quality of included studies using the AMSTAR2 tool. Results: Of 351 identified records, 40 SRs met inclusion criteria, encompassing 926 RCTs, 63,493 patients, 13 types of acupuncture interventions and 29 outcomes. Acupuncture interventions, particularly fire needling, CPBLC, Fu’s subcutaneous needling, plum-blossom needle, multi-acupuncture and multi-acupuncture + pharmacotherapy, showed the most robust benefits in improving effective rate, reducing visual analog scale (VAS) scores, and decreasing adverse reactions in PHN treatment. Despite most SRs reporting positive outcomes, the quality was generally low by AMSTAR2. Conclusion: Acupuncture could be a valuable adjunct to standard PHN treatment, offering benefits in overall efficacy, pain management and treatment safety. However, high-quality clinical trials and systematic reviews are needed to confirm these preliminary results and guide clinical practice.
- 1 June 2026
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 19, 1-18
Open AccessAcupuncture for Postherpetic Neuralgia: An Evidence Mapping
Objective: This study is to systematically evaluate the efficacy of acupuncture for PHN and provide a visual overview of treatment landscape. Methods: A systematic search was conducted in PubMed, Embase, Web of Science, China National Knowledge Infrastructure (CNKI), Chinese Scientific Journals Database (VIP), and Wanfang Database for systematic reviews (SRs) on acupuncture for PHN up to Apr 18, 2025. Studies were included if they were SRs of randomized controlled trials (RCTs) assessing traditional Chinese acupuncture interventions for PHN, and excluded if they involved non-traditional acupuncture, herpes zoster, or PHN prevention research. Two independent reviewers utilized Excel, EndNote 20, and R software for data analysis and assessed the quality of included studies using the AMSTAR2 tool. Results: Of 351 identified records, 40 SRs met inclusion criteria, encompassing 926 RCTs, 63,493 patients, 13 types of acupuncture interventions and 29 outcomes. Acupuncture interventions, particularly fire needling, CPBLC, Fu’s subcutaneous needling, plum-blossom needle, multi-acupuncture and multi-acupuncture + pharmacotherapy, showed the most robust benefits in improving effective rate, reducing visual analog scale (VAS) scores, and decreasing adverse reactions in PHN treatment. Despite most SRs reporting positive outcomes, the quality was generally low by AMSTAR2. Conclusion: Acupuncture could be a valuable adjunct to standard PHN treatment, offering benefits in overall efficacy, pain management and treatment safety. However, high-quality clinical trials and systematic reviews are needed to confirm these preliminary results and guide clinical practice.
- Open Access
- 2 February 2026
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 21, 106-113
Mechanisms of electroacupuncture for the treatment of Alzheimer's disease by activating Wnt/β-catenin pathway to improve blood-brain barrier function
- 2 February 2026
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 21, 106-113
Open AccessMechanisms of electroacupuncture for the treatment of Alzheimer's disease by activating Wnt/β-catenin pathway to improve blood-brain barrier function
- Open Access
- 1 February 2026
- Published by Taylor & Francis in Journal of Hepatocellular Carcinoma
- Vol. ume 13, 1-15
Electroacupuncture and Moxibustion Regulate Aerobic Glycolysis and Alleviate Tumor Progression in Mice with Hepatocellular Carcinoma
Aerobic glycolysis is crucial in the proliferation, metastasis, immunosuppression of hepatocellular carcinoma (HCC). We established mice model with HCC to explore whether electroacupuncture and moxibustion can alleviate HCC mice by inhibiting NSUN2-mediated aerobic glycolysis. HCC mice model was established by intraperitoneal injection of diethylnitrosamine combined with carbon tetrachloride. In the moxibustion and electroacupuncture groups, the acupoints “Ganshu” and “Zusanli” (bilateral) were selected for intervention. Enzyme-linked immunosorbent assay quantified the serum levels. Immunohistochemistry/Western blotting, quantitative real-time PCR assessed protein and mRNA expressions of aerobic glycolysis. MRM-based targeted metabolomics quantified hepatic energy metabolism alterations. After HCC model completion on week 28, macroscopic examination revealed pronounced hepatomegaly with evident morphological distortion. The hepatic surface exhibited a coarse and irregular texture, accompanied by varying degrees of adhesions between adjacent liver lobes. Notably, large, well-defined tumors presenting in either whitish or dark-red appearances were observed scattered across the liver parenchyma. Following a total intervention period of 26 weeks, electroacupuncture and moxibustion significantly decreased the number of liver tumor, tumor load, mean tumor diameter and tumor volume compared to the model group (P < 0.05). Furthermore, the spleen and liver index were also significantly lowered (P < 0.05). A significant decrease was observed in the protein levels of serum AFP and AFP-L3 after treatment (P < 0.05). The protein and mRNA expression levels of NSUN2 and PKM2 were significantly downregulated (P < 0.01). Consistent with the inhibition of glycolytic flux, the protein expression of enzyme hexokinase 2 (HK2) was profoundly reduced (P < 0.001). Meanwhile, moxibustion decreased in the hepatic content of early glycolytic intermediates, glucose-6-phosphate (G6P) and fructose 6 phosphate (F6P) (P < 0.01), and electroacupuncture just decreased G6P (P < 0.001). Conversely, the level of phosphoenolpyruvate, a high-energy intermediate preceding the final step of glycolysis, was significantly elevated and increased (P < 0.001). The study reveals that both electroacupuncture and moxibustion alleviate tumor proliferation in HCC mice by suppressing the NSUN2-PKM2 glycolytic axis, thereby highlighting this pathway as a novel metabolic target for non-pharmacological intervention; moreover, moxibustion uniquely exhibits the potential to induce a more extensive metabolic stress response. The observed reductions in tumor burden and key biomarkers corroborate the therapeutic potential of this approach. Collectively, these preclinical findings suggest that electroacupuncture and moxibustion, as non-pharmacological adjunctive therapies, hold translational potential for modulating tumor metabolism and slowing HCC progression, warranting further clinical investigation.
- 1 February 2026
- Published by Taylor & Francis in Journal of Hepatocellular Carcinoma
- Vol. ume 13, 1-15
Open AccessElectroacupuncture and Moxibustion Regulate Aerobic Glycolysis and Alleviate Tumor Progression in Mice with Hepatocellular Carcinoma
Aerobic glycolysis is crucial in the proliferation, metastasis, immunosuppression of hepatocellular carcinoma (HCC). We established mice model with HCC to explore whether electroacupuncture and moxibustion can alleviate HCC mice by inhibiting NSUN2-mediated aerobic glycolysis. HCC mice model was established by intraperitoneal injection of diethylnitrosamine combined with carbon tetrachloride. In the moxibustion and electroacupuncture groups, the acupoints “Ganshu” and “Zusanli” (bilateral) were selected for intervention. Enzyme-linked immunosorbent assay quantified the serum levels. Immunohistochemistry/Western blotting, quantitative real-time PCR assessed protein and mRNA expressions of aerobic glycolysis. MRM-based targeted metabolomics quantified hepatic energy metabolism alterations. After HCC model completion on week 28, macroscopic examination revealed pronounced hepatomegaly with evident morphological distortion. The hepatic surface exhibited a coarse and irregular texture, accompanied by varying degrees of adhesions between adjacent liver lobes. Notably, large, well-defined tumors presenting in either whitish or dark-red appearances were observed scattered across the liver parenchyma. Following a total intervention period of 26 weeks, electroacupuncture and moxibustion significantly decreased the number of liver tumor, tumor load, mean tumor diameter and tumor volume compared to the model group (P < 0.05). Furthermore, the spleen and liver index were also significantly lowered (P < 0.05). A significant decrease was observed in the protein levels of serum AFP and AFP-L3 after treatment (P < 0.05). The protein and mRNA expression levels of NSUN2 and PKM2 were significantly downregulated (P < 0.01). Consistent with the inhibition of glycolytic flux, the protein expression of enzyme hexokinase 2 (HK2) was profoundly reduced (P < 0.001). Meanwhile, moxibustion decreased in the hepatic content of early glycolytic intermediates, glucose-6-phosphate (G6P) and fructose 6 phosphate (F6P) (P < 0.01), and electroacupuncture just decreased G6P (P < 0.001). Conversely, the level of phosphoenolpyruvate, a high-energy intermediate preceding the final step of glycolysis, was significantly elevated and increased (P < 0.001). The study reveals that both electroacupuncture and moxibustion alleviate tumor proliferation in HCC mice by suppressing the NSUN2-PKM2 glycolytic axis, thereby highlighting this pathway as a novel metabolic target for non-pharmacological intervention; moreover, moxibustion uniquely exhibits the potential to induce a more extensive metabolic stress response. The observed reductions in tumor burden and key biomarkers corroborate the therapeutic potential of this approach. Collectively, these preclinical findings suggest that electroacupuncture and moxibustion, as non-pharmacological adjunctive therapies, hold translational potential for modulating tumor metabolism and slowing HCC progression, warranting further clinical investigation.
- Open Access
- 1 January 2026
- Published by Compuscript, Ltd. in BIO Integration
- Vol. 7 (1)
Single-Cell Immune Microenvironment Atlas of Human Myocardial Infarction Focusing on Myeloid Cells and Functional Differentiation of Macrophage Subtypes
Background: Myocardial infarction (MI) is characterized by extensive immune activation and dynamic remodeling of the cardiac microenvironment, in which myeloid cells play critical roles in regulating inflammation and tissue repair. However, the cellular heterogeneity, developmental trajectories, and intercellular communication networks of myeloid cell subtypes during MI remain incompletely understood. Methods: Single-cell RNA sequencing (scRNA-seq) data from MI tissues were integrated to construct a comprehensive immune atlas. Cell clustering, differential expression, cell cycle, and functional enrichment analyses were performed to characterize cellular composition and biological functions. CytoTRACE, Monocle2, and Slingshot were applied to investigate macrophage differentiation trajectories, whereas transcriptional regulatory network analysis and CellChat were used to identify regulatory modules and intercellular communication pathways. Results: A total of 44,574 high-quality cells comprising 24 cell types were identified, which revealed prominent myeloid cell accumulation and enhanced immune activation in infarcted tissues. Macrophages were enriched in infarcted regions and exhibited increased proliferative activity and immune-related pathway activation. Four transcriptionally distinct macrophage subtypes were identified (C0 GPNMB + , C1 S100A4 + , C2 IL1B + , and C3 EGR1 + ), among which C 1 S100A4 + macrophages predominated, displayed the strongest proliferative ability, and expressed high levels of inflammatory mediators, including IL1B, CCL3, and CXCL8. Trajectory and regulatory analyses revealed dynamic macrophage differentiation and subtype-specific transcriptional programs. Cell-cell communication analysis identified C1 S100A4 + macrophages as a central signaling hub interacting with endothelial cells, fibroblasts, and immune cells through CXCL, MHC-II, and TNF pathways, thereby suggesting their critical role in post-MI inflammatory remodeling. Conclusion: This study provided a comprehensive single-cell immune atlas of MI and systematically elucidated the heterogeneity, developmental dynamics, transcriptional regulation, metabolic reprogramming, and intercellular communication of macrophage subtypes. C1 S100A4 + macrophages were identified as a key inflammatory population orchestrating immune remodeling after MI. Our findings provide insights into the cellular mechanisms underlying cardiac injury that may offer potential therapeutic targets for precision immunomodulation in MI.
- 1 January 2026
- Published by Compuscript, Ltd. in BIO Integration
- Vol. 7 (1)
Open AccessSingle-Cell Immune Microenvironment Atlas of Human Myocardial Infarction Focusing on Myeloid Cells and Functional Differentiation of Macrophage Subtypes
Background: Myocardial infarction (MI) is characterized by extensive immune activation and dynamic remodeling of the cardiac microenvironment, in which myeloid cells play critical roles in regulating inflammation and tissue repair. However, the cellular heterogeneity, developmental trajectories, and intercellular communication networks of myeloid cell subtypes during MI remain incompletely understood. Methods: Single-cell RNA sequencing (scRNA-seq) data from MI tissues were integrated to construct a comprehensive immune atlas. Cell clustering, differential expression, cell cycle, and functional enrichment analyses were performed to characterize cellular composition and biological functions. CytoTRACE, Monocle2, and Slingshot were applied to investigate macrophage differentiation trajectories, whereas transcriptional regulatory network analysis and CellChat were used to identify regulatory modules and intercellular communication pathways. Results: A total of 44,574 high-quality cells comprising 24 cell types were identified, which revealed prominent myeloid cell accumulation and enhanced immune activation in infarcted tissues. Macrophages were enriched in infarcted regions and exhibited increased proliferative activity and immune-related pathway activation. Four transcriptionally distinct macrophage subtypes were identified (C0 GPNMB + , C1 S100A4 + , C2 IL1B + , and C3 EGR1 + ), among which C 1 S100A4 + macrophages predominated, displayed the strongest proliferative ability, and expressed high levels of inflammatory mediators, including IL1B, CCL3, and CXCL8. Trajectory and regulatory analyses revealed dynamic macrophage differentiation and subtype-specific transcriptional programs. Cell-cell communication analysis identified C1 S100A4 + macrophages as a central signaling hub interacting with endothelial cells, fibroblasts, and immune cells through CXCL, MHC-II, and TNF pathways, thereby suggesting their critical role in post-MI inflammatory remodeling. Conclusion: This study provided a comprehensive single-cell immune atlas of MI and systematically elucidated the heterogeneity, developmental dynamics, transcriptional regulation, metabolic reprogramming, and intercellular communication of macrophage subtypes. C1 S100A4 + macrophages were identified as a key inflammatory population orchestrating immune remodeling after MI. Our findings provide insights into the cellular mechanisms underlying cardiac injury that may offer potential therapeutic targets for precision immunomodulation in MI.
- Open Access
- 1 June 2025
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 18, 3289-3297
Electroacupuncture Prevent and Treat Perioperative Cognitive Impairment in Elderly Patients Undergoing Hip Surgery: A Protocol for a Randomized Controlled Trial
Background: Electroacupuncture is effective in treating perioperative neurocognitive disorder (PND) and has good application prospects in the prevention and treatment of PND. However, the mechanism of electroacupuncture treatment for PND is comparatively unexplored. Methods/Design: This is a single-center clinical, prospective randomized controlled clinical trial protocol. 180 patients will be randomly divided into the treatment group and the control group in a ratio of 1:1. Both groups of subjects received routine care, while the treatment group will receive electroacupuncture treatment twice a day for 10 days. Acupoints will include Baihui (DU20), Shangxing (DU23), Yintang (EX-HN3), Meichong (BL3), Fengchi (GB20), Cuanzhu (BL2), Laogong (PC8), Hegu (LI4), and Zusanli (ST36). The primary outcome measure is the Mini-mental State Examination (MMSE). And the secondary outcome measures are the Confusion Assessment Method (CAM), Visual Analog Scale (VAS), Pittsburgh Sleep Quality Index (PSQI), Generalized Anxiety Disorder (GAD-7), Patient Health Questionnaire-9 (PHQ-9), and interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), neuron-specific enolase (NSE), superoxide dismutase (SOD), central nervous system-specific protein (s100-β) in serum. The outcome measures will be evaluated at baseline, during treatment and 1 week after treatment. What’s more, the incidence of non-delirium complications and mortality within 30 days will also be measured. Discussion: Results of this trial are expected to clarify the value of electroacupuncture performed on perioperative cognitive impairment in elderly patients undergoing hip surgery. Ethics: This trial has been approved by the Ethics Committee of Yueyang Hospital of Integrated Traditional Chinese and Western Medicine (No.2024– 037). Trial Registration: International Traditional Medicine Clinical Trial Registry, ITMCTR2024000298 (http://itmctr.ccebtcm.org.cn/), registered on 25 August, 2024. The trial will comply with the Declaration of Helsinki.
- 1 June 2025
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 18, 3289-3297
Open AccessElectroacupuncture Prevent and Treat Perioperative Cognitive Impairment in Elderly Patients Undergoing Hip Surgery: A Protocol for a Randomized Controlled Trial
Background: Electroacupuncture is effective in treating perioperative neurocognitive disorder (PND) and has good application prospects in the prevention and treatment of PND. However, the mechanism of electroacupuncture treatment for PND is comparatively unexplored. Methods/Design: This is a single-center clinical, prospective randomized controlled clinical trial protocol. 180 patients will be randomly divided into the treatment group and the control group in a ratio of 1:1. Both groups of subjects received routine care, while the treatment group will receive electroacupuncture treatment twice a day for 10 days. Acupoints will include Baihui (DU20), Shangxing (DU23), Yintang (EX-HN3), Meichong (BL3), Fengchi (GB20), Cuanzhu (BL2), Laogong (PC8), Hegu (LI4), and Zusanli (ST36). The primary outcome measure is the Mini-mental State Examination (MMSE). And the secondary outcome measures are the Confusion Assessment Method (CAM), Visual Analog Scale (VAS), Pittsburgh Sleep Quality Index (PSQI), Generalized Anxiety Disorder (GAD-7), Patient Health Questionnaire-9 (PHQ-9), and interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), neuron-specific enolase (NSE), superoxide dismutase (SOD), central nervous system-specific protein (s100-β) in serum. The outcome measures will be evaluated at baseline, during treatment and 1 week after treatment. What’s more, the incidence of non-delirium complications and mortality within 30 days will also be measured. Discussion: Results of this trial are expected to clarify the value of electroacupuncture performed on perioperative cognitive impairment in elderly patients undergoing hip surgery. Ethics: This trial has been approved by the Ethics Committee of Yueyang Hospital of Integrated Traditional Chinese and Western Medicine (No.2024– 037). Trial Registration: International Traditional Medicine Clinical Trial Registry, ITMCTR2024000298 (http://itmctr.ccebtcm.org.cn/), registered on 25 August, 2024. The trial will comply with the Declaration of Helsinki.
- 22 March 2025
- Published by Elsevier in Journal of Integrative Medicine
- Vol. 23 (3) , 256-263
Current situation of clinical trial registration in acupuncture anesthesia: A scoping review
- 22 March 2025
- Published by Elsevier in Journal of Integrative Medicine
- Vol. 23 (3) , 256-263
Current situation of clinical trial registration in acupuncture anesthesia: A scoping review
- 15 March 2025
- Published by Springer Nature in Cognitive Neurodynamics
- Vol. 19 (1) , 1-14
The potential associations between acupuncture sensation and brain functional network: a EEG study
Acupuncture has been widely used as an effective treatment for post-stroke rehabilitation. However, the potential association between acupuncture sensation, an important factor influencing treatment efficacy, and brain functional network is unclear. This research sought to reveal and quantify the changes in brain functional network associated with acupuncture sensation. So multi-channel EEG signals were collected from 30 healthy participants and the Massachusetts General Hospital Acupuncture Sensation Scale (MASS) was utilized to assess their needling sensations. Phase Lag Index (PLI) was used to construct the brain functional network, which was analyzed with graph theoretic methods. It showed that in the needle insertion (NI) state the MASS Index was significantly higher than in the needle retention (NR) state (P < 0.001), and the mean values of PLI were also higher than in the Pre-Rest state and NR state significantly (P < 0.01). In the NI state global efficiency, local efficiency, nodal efficiency, and degree centrality were significantly higher than in the Pre-Rest state and the NR state (P < 0.05), while the opposite is true for the shortest path length (P < 0.01). Then Pearson correlation analysis showed a correlation between MASS Index and graph theory metrics (P < 0.05). Finally, Support Vector Regression (SVR) was used to predict the MASS Index with a minimum mean absolute error of 0.65. These findings suggest that the NI state of acupuncture treatment changes the structure of the brain functional network and affects the graph theory metrics of the brain functional network, which may be an objective biomarker for quantitative evaluation of acupuncture sensation.
- 15 March 2025
- Published by Springer Nature in Cognitive Neurodynamics
- Vol. 19 (1) , 1-14
The potential associations between acupuncture sensation and brain functional network: a EEG study
Acupuncture has been widely used as an effective treatment for post-stroke rehabilitation. However, the potential association between acupuncture sensation, an important factor influencing treatment efficacy, and brain functional network is unclear. This research sought to reveal and quantify the changes in brain functional network associated with acupuncture sensation. So multi-channel EEG signals were collected from 30 healthy participants and the Massachusetts General Hospital Acupuncture Sensation Scale (MASS) was utilized to assess their needling sensations. Phase Lag Index (PLI) was used to construct the brain functional network, which was analyzed with graph theoretic methods. It showed that in the needle insertion (NI) state the MASS Index was significantly higher than in the needle retention (NR) state (P < 0.001), and the mean values of PLI were also higher than in the Pre-Rest state and NR state significantly (P < 0.01). In the NI state global efficiency, local efficiency, nodal efficiency, and degree centrality were significantly higher than in the Pre-Rest state and the NR state (P < 0.05), while the opposite is true for the shortest path length (P < 0.01). Then Pearson correlation analysis showed a correlation between MASS Index and graph theory metrics (P < 0.05). Finally, Support Vector Regression (SVR) was used to predict the MASS Index with a minimum mean absolute error of 0.65. These findings suggest that the NI state of acupuncture treatment changes the structure of the brain functional network and affects the graph theory metrics of the brain functional network, which may be an objective biomarker for quantitative evaluation of acupuncture sensation.
- Open Access
Investigating the efficacy of acupuncture in treating patients with metabolic-associated fatty liver disease: a protocol for a randomised controlled clinical trial
Introduction: Acupuncture is widely used for metabolic-associated fatty liver disease (MAFLD) treatment; however, the clinical efficacy has not been confirmed due to the lack of high-level evidence-based clinical practice. The purpose of this study is to design a research protocol that will be used to determine the efficacy of acupuncture versus sham acupuncture (SHA) for MAFLD treatment.Methods and analysis: This will be a multicentre, randomised and sham-controlled trial. Ninety-eight participants with MAFLD will be enrolled in this trial. Participants will be randomly assigned in a 1:1 ratio to receive acupuncture or SHA for 12 weeks. The primary outcome is the rate of patients with a 30% relative decline in liver fat after 12 weeks of treatment in MRI-proton density fat fraction (MRI-PDFF), which will be obtained by quantitative chemical shift imaging such as the multipoint Dixon method at 0, 12 and 24 weeks. Secondary outcomes include the changes in the relative liver fat content measured by MRI-PDFF, magnetic resonance elastography, liver function, lipid metabolism, homeostatic model assessment for insulin resistance (HOMA-IR) and serum high sensitivity C reactive protein, which will be obtained at 0, 6, 12 and 24 weeks. Body measurement indicators (body mass index, waist circumference, hip circumference and waist-to-hip ratio) will be obtained at 0, 3, 6, 9, 12 and 24 weeks. The alteration in the gut microbiota composition and its metabolism will be assessed by 16S ribosomal RNA sequencing and liquid chromatography-mass spectrometry at 0 and 12 weeks.Ethics and dissemination: This study protocol has been approved by the ethics committee of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine (2023-1347-114-01). The results of this study will be published in a peer-reviewed journal and presented at academic conferences.Trial registration number: ChiCTR2300075701.
Open AccessInvestigating the efficacy of acupuncture in treating patients with metabolic-associated fatty liver disease: a protocol for a randomised controlled clinical trial
Introduction: Acupuncture is widely used for metabolic-associated fatty liver disease (MAFLD) treatment; however, the clinical efficacy has not been confirmed due to the lack of high-level evidence-based clinical practice. The purpose of this study is to design a research protocol that will be used to determine the efficacy of acupuncture versus sham acupuncture (SHA) for MAFLD treatment.Methods and analysis: This will be a multicentre, randomised and sham-controlled trial. Ninety-eight participants with MAFLD will be enrolled in this trial. Participants will be randomly assigned in a 1:1 ratio to receive acupuncture or SHA for 12 weeks. The primary outcome is the rate of patients with a 30% relative decline in liver fat after 12 weeks of treatment in MRI-proton density fat fraction (MRI-PDFF), which will be obtained by quantitative chemical shift imaging such as the multipoint Dixon method at 0, 12 and 24 weeks. Secondary outcomes include the changes in the relative liver fat content measured by MRI-PDFF, magnetic resonance elastography, liver function, lipid metabolism, homeostatic model assessment for insulin resistance (HOMA-IR) and serum high sensitivity C reactive protein, which will be obtained at 0, 6, 12 and 24 weeks. Body measurement indicators (body mass index, waist circumference, hip circumference and waist-to-hip ratio) will be obtained at 0, 3, 6, 9, 12 and 24 weeks. The alteration in the gut microbiota composition and its metabolism will be assessed by 16S ribosomal RNA sequencing and liquid chromatography-mass spectrometry at 0 and 12 weeks.Ethics and dissemination: This study protocol has been approved by the ethics committee of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine (2023-1347-114-01). The results of this study will be published in a peer-reviewed journal and presented at academic conferences.Trial registration number: ChiCTR2300075701.